Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

76.84
-0.3400-0.44%
Post-market: 76.880.0400+0.05%19:30 EDT
Volume:1.52M
Turnover:117.29M
Market Cap:10.68B
PE:-10.70
High:77.70
Open:77.30
Low:76.65
Close:77.18
52wk High:88.31
52wk Low:35.22
Shares:139.02M
Float Shares:138.02M
Volume Ratio:0.94
T/O Rate:1.10%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-61.58
PE(LYR):-11.75

Loading ...

Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 shares for $278,285‬

Reuters
·
Jun 24

Cytokinetics Inc : Mizuho Raises Target Price to $118 From $100

THOMSON REUTERS
·
Jun 23

Cytokinetics (CYTK) Stock Could Be 15% Undervalued After Myqorzo Approval

Simply Wall St.
·
Jun 19

Cytokinetics grants inducement equity awards to 12 new employees, sets options at $71.38

Reuters
·
Jun 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jun 18

Movement Alert|Cytokinetics Rises 5.17% in Regular Trading, Trading at $78.995

Market Focus
·
Jun 18

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and American Well (AMWL)

TIPRANKS
·
Jun 17

Cytokinetics Price Target Maintained With a $102.00/Share by Needham

Dow Jones
·
Jun 17

Cytokinetics: Competitive Overhang Eases After EDG-7500 Data, Analyst Reiterates Buy and $102 Price Target

TIPRANKS
·
Jun 17

S&P 500 Futures Rise In Premarket Trading; Western Digital, Agilent Technologies Lead

Dow Jones
·
Jun 16

Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $528,450

Reuters
·
Jun 16

Cytokinetics EVP R&D Malik Fady Ibraham disposes of 3,500 common shares worth $237,930

Reuters
·
Jun 10

Cytokinetics posts GALACTIC-HF presentation on serum magnesium outcomes in HFrEF

Reuters
·
Jun 09

Cytokinetics Announces Call for Proposals for Annual Corporate Giving Program

THOMSON REUTERS
·
Jun 08

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Jun 06

Cytokinetics director Edward M. Kaye MD disposes of 2,933 common shares for $223,142.97

Reuters
·
Jun 02

Cytokinetics EVP, Chief Commercial Officer Andrew Callos disposes of 15,000 common shares for $1.11 million

Reuters
·
Jun 02

Cytokinetics director B. Lynne Parshall disposes of USD 370,400 in common shares

Reuters
·
Jun 02

Cytokinetics - Myqorzo Launched in Germany Following European Commission Approval in February 2026

THOMSON REUTERS
·
Jun 01